Determine the necessary mass, volume, or concentration for preparing a solution.
C494293-NM, croscarmellose sodium, is a superdisintegrant specifically developed for manufacturing tablets and capsules. Its unique performance attributes have established C494293-NM as a globally accepted product in the pharmaceutical and nutritional industries.
The fibrous nature of C494293-NM possesses a wicking effect, which is responsible for rapid capillary transport into the tablet matrix. As a result, the C494293-NM use level can remain low while still providing superior tablet disintegration properties.
JRS Pharma produces two croscarmellose sodium grades: C494293-NM and C494293-GF (GMO-Free). Their specifications and functional performances are similar.
Benefits:
1.Fast tablet disintegration
2.Good flowability and mixing properties
3.Excellent API stability
4.Performs well in both direct compression and granulation processes
5.Cost-effectiveness
6.Guaranteed supply chain security
Product specifications and parameters:
|
| Isómeros SMILES | COC1=CC=CC(=C1O)C(=O)OCC2=NC(=NO2)C3=CC=CS3 |
|---|---|
| PubChem CID | 17397716 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Sensibilidad | Moisture sensitive |
|---|---|
| Punto de fusión (°C) | >205ºC |
| 1. Gu Yuang, Yao Yu, Lou Qiuwen, Zhu Xinyan, Lan Ju, Gao Chenshu, Wu Shuangshuang, Liang Jingjia, Xu Cenglin, Wang Yi, Cheng Heming, Chen Zhong. (2025) Model-Dependent Attenuation of Seizures by Cinnabar. Neuroscience Bulletin, [PMID:40783890] [10.1007/s12264-025-01480-7] |